Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

Abstract Background Several studies have been focusing on the effect of omega-3 polyunsaturated fatty acids on modulation of inflammatory markers in several cardiopathies. Although immunoregulatory dysfunction has been associated to the chronic cardiac involvement in Chagas disease, there is no stud...

Full description

Bibliographic Details
Main Authors:	Paula Simplício da Silva, Mauro Felippe Felix Mediano, Gilberto Marcelo Sperandio da Silva, Patricia Dias de Brito, Claudia Santos de Aguiar Cardoso, Cristiane Fonseca de Almeida, Luiz Henrique Conde Sangenis, Roberta Olmo Pinheiro, Alejandro Marcel Hasslocher-Moreno, Pedro Emmanuel Alvarenga Americano do Brasil, Andrea Silvestre de Sousa
Format:	Article
Language:	English
Published:	BMC 2017-06-01
Series:	Nutrition Journal
Subjects:	Chagas disease Chagas cardiomyopathy Omega-3 Cytokines Lipid profile
Online Access:	http://link.springer.com/article/10.1186/s12937-017-0259-0

Similar Items

A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: A pilot single-arm clinical trial
by: Luiz Fernando Rodrigues Junior, et al.
Published: (2020-01-01)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
by: Marcelo Teixeira Holanda, et al.
Published: (2018-09-01)

Comparação do desfecho entre a cardiopatia chagásica e a miocardiopatia dilatada idiopática Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy
by: Amanda Pires Barbosa, et al.
Published: (2011-12-01)

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Maykon Tavares de Oliveira, et al.
Published: (2021-09-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
by: Elieusa e Silva Sampaio, et al.

Assessment of syndecan-4 expression in the hearts of Trypanosoma cruzi-infected mice and human subjects with chronic Chagas disease cardiomyopathy
by: Ticiana Ferreira Larocca, et al.
Published: (2018-12-01)

Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study
by: Mauro Felippe Felix Mediano, et al.
Published: (2016-06-01)

Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al.

PREDICTIVE FACTORS FOR THE PROGRESSION OF CHRONIC CHAGAS CARDIOMYOPATHY IN PATIENTS WITHOUT LEFT VENTRICULAR DYSFUNCTION
by: Silvana de Araújo SILVA, et al.
Published: (2015-04-01)

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
by: Fernanda de Souza Nogueira Sardinha Mendes, et al.
Published: (2020-05-01)

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood
by: Marisa Liliana Fernández, et al.

Immunopathologic studies in myocardial biopsies of patients with Chagas' disease and idiopathic cardiomyopathy
by: Maria de Lourdes Higuchi, et al.
Published: (1986-04-01)

Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death
by: Antonia Pino-Marín, et al.
Published: (2021-04-01)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2019-08-01)

Anatomopathological Aspects of Acute Chagas Myocarditis by Oral Transmission
by: Dilma do Socorro Moraes de Souza, et al.
Published: (2016-07-01)

Chagas cardiomyopathy and serologic testing in a small rural hospital in Chiapas, Mexico Miocardiopatía chagásica y pruebas serológicas de enfermedad de Chagas en un hospital rural pequeño de Chiapas, México
by: Linnea Capps, et al.
Published: (2004-05-01)

Acometimento cardíaco em Casos de Doença de Chagas Aguda da Amazônia Cardiac involvement in Acute Chagas' Disease Cases in the Amazon region
by: João Marcos Barbosa-Ferreira, et al.
Published: (2010-06-01)

Chagas disease cardiomyopathy: current concepts of an old disease Cardiomiopatia chagásica: conceitos atuais de doença antiga
by: Angelina M.B. Bilate, et al.
Published: (2008-04-01)

Clinical characterization of chronic chagasic cardiomyopathy in dogs
by: João Paulo da E. Pascon, et al.
Published: (2010-02-01)

Chagas Disease: From Discovery to a Worldwide Health Problem
by: Kárita Cláudia Freitas Lidani, et al.
Published: (2019-07-01)

Agreement between upper endoscopy and esophagography in the diagnosis of megaesophagus in Chagas disease
by: Fernando de Barros, et al.
Published: (2019-03-01)

Função do átrio esquerdo na miocardiopatia chagásica Function of the left atrium in the Chagas' cardiomyopathy
by: Maria do Carmo Pereira Nunes, et al.
Published: (2005-06-01)

Association of caspase-1 polymorphisms with Chagas cardiomyopathy among individuals in Santa Cruz, Bolivia
by: Katherine Yih-Jia Fu, et al.

Chagas Disease: Where to now?
by: Louise G. Shewan, et al.
Published: (2016-01-01)

FIRST REPORT OF ACUTE CHAGAS DISEASE BY VECTOR TRANSMISSION IN RIO DE JANEIRO STATE, BRAZIL
by: Luiz Henrique Conde SANGENIS, et al.
Published: (2015-08-01)

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice
by: Andréa P de Souza, et al.
Published: (2010-09-01)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
by: Walace de Souza Pimentel, et al.
Published: (2012-09-01)

Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2020-05-01)

Avaliação do metabolismo dos fosfatos de alta energia em pacientes com doença de Chagas Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease
by: Ana Maria Betim Paes Leme, et al.
Published: (2010-08-01)

Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease
by: Matheus Barbosa de Miranda, et al.

Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
by: Anis Rassi Jr, et al.

Feasibility of a Combined Mobile-Health Electrocardiographic and Rapid Diagnostic Test Screening for Chagas-Related Cardiac Alterations
by: Michele Spinicci, et al.
Published: (2021-09-01)

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
by: J Antonio Marin-Neto, et al.
Published: (2009-07-01)

Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy
by: Cunha-Neto E., et al.
Published: (1998-01-01)

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research
by: Julio Scharfstein, et al.
Published: (2009-07-01)

Association between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease
by: Bárbara Carolina Silva Almeida, et al.
Published: (2018-04-01)

Reassessment of quality of life domains in patients with compensated Chagas heart failure after participating in a cardiac rehabilitation program
by: Mauro Felippe Felix Mediano, et al.

Serum cytokines in chronic Chagas' disease
by: Ward Laura S., et al.
Published: (1999-01-01)

Curcumin exerts anti-inflammatory and vasoprotective effects through amelioration of NFAT-dependent endothelin-1 production in mice with acute Chagas cardiomyopathy
by: Matías Hernández, et al.
Published: (2018-07-01)

Cannot write session to /tmp/vufind_sessions/sess_1jg462ckk3nn3kc20v1q5h01bi